American Pharmaceutical Partners, Inc. is a specialty drug company that develops, manufactures and markets injectable pharmaceutical products, focusing on the oncology, anti-infective and critical care markets. The company is one of the largest producers of injectables, with more than 100 generic products in more than 300 dosages and formulations. APP has acquired the exclusive North American rights to manufacture and market a proprietary injectable oncology product, currently in Phase III clinical trials for metastatic breast cancer and being studied in a variety of other cancers. For more information, visit APP's website at www.appdrugs.com .